| Prokaryote-Specific DNA | p value | |
---|---|---|---|
+ n = 26 | − n = 55 |  | |
Age, media (IQR) | 72 (65–75) | 69 (57–78) | 0.46 |
Male gender, n (%) | 20 (76.9) | 32 (58.2) | 0.10 |
BMI, media (IQR) | 23.9 (21.5–25.4) | 24.1 (23.2–26.1) | 0.55 |
Hypertension | 16 (61.5) | 37 (67.3) | 0.61 |
Diabetes | 8 (30.8) | 11 (20.0) | 0.29 |
AF | 16 (61.5) | 33 (60.0) | 0.62 |
CAD | 9 (34.6) | 12 (21.8) | 0.22 |
Prior stroke | 7 (26.9) | 11 (20.0) | 0.48 |
Smoking | 11 (42.3) | 13 (23.6) | 0.09 |
Alcohol drinking | 10 (38.5) | 9 (16.4) | 0.03* |
Intravenous alteplase use | 3 (11.5) | 9 (16.4) | 0.74 |
NIHSS score, media (IQR) | 16 (11–22) | 18 (14–25) | 0.08 |
Stroke sub-type, n (%) | Â | Â | 0.19 |
 LAA | 7 (26.9) | 13 (23.6) |  |
 Cardioembolic | 16 (61.5) | 29 (52.8) |  |
 Others or uncertain | 3 (11.6) | 13 (23.6) |  |
HDL, mmol/L, media (IQR) | 1.18 (0.84–1.40) | 1.11 (0.87–1.38) | 0.79 |
LDL, mmol/L, media (IQR) | 2.68 (1.44–3.06) | 2.49 (2.01–2.98) | 0.98 |
TG, mmol/L, media (IQR) | 0.68 (0.53–1.06) | 0.96 (0.67–1.26) | 0.08 |
TC, mmol/L, media (IQR) | 3.89 (3.21–4.87) | 4.26 (3.43–4.55) | 0.98 |
Leukocyte, ×109/L, media (IQR) | 10.01 (8.06–13.06) | 9.39 (7.88–12.60) | 0.27 |
CRP, mg/L, media (IQR) | 3.55 (0.50-13.09) | 9.9 (3.60–23.50) | 0.17 |
Occlusion site, n (%) | Â | Â | 0.75 |
 ICA | 9 (34.6) | 19 (34.5) |  |
 MCA | 15 (57.7) | 28 (50.9) |  |
 Vertebrobasilar | 2 (7.7) | 8 (14.5) |  |
Procedure time, media (IQR) | 66 (55–95) | 85 (58–120) | 0.14 |
Thrombus fragmentation, n (%) | 9 (34.6) | 30 (54.5) | 0.09 |
Successful reperfusion, n (%) | 24 (92.3) | 42 (76.4) | 0.13 |